[
    [
        {
            "time": "2018-01-01",
            "original_text": "These 12 Drugs Launching In 2018 Are Headed For Blockbuster Status",
            "features": {
                "keywords": [
                    "Drugs",
                    "Launching",
                    "Blockbuster",
                    "2018"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "These 12 Drugs Launching In 2018 Are Headed For Blockbuster Status",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-01-01",
            "original_text": "Novo Nordisk: Ozempic Approved In Japan To Treat Adults With Type 2 Diabetes",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "Ozempic",
                    "Approved",
                    "Japan",
                    "Type 2 Diabetes"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Novo Nordisk: Ozempic Approved In Japan To Treat Adults With Type 2 Diabetes",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]